Vendor Analysis
published on May 15, 2013
Report Overview:
This NelsonHall vendor assessment analyzes Genpact's offerings and capabilities in life insurance BPO. Genpact is one of a number of life insurance BPO companies analyzed in NelsonHall's comprehensive industry analysis programs.
Who is this Report for:
NelsonHall's life insurance Vendor Assessment for Genpact is a comprehensive assessment of Genpact's life insurance offerings and capabilities designed for:
- Sourcing managers monitoring the capabilities of existing suppliers of life, annuities, investments and pensions services and identifying vendor suitability within this space
- Vendor marketing, sales and business managers looking to benchmark themselves against their peers
- Financial analysts and investors specializing in the BPO services sector.
Scope of this Report:
The report provides a comprehensive and objective analysis of Genpact's life insurance BPO offerings, capabilities, and market and financial strength, including:
- Analysis of the company's offerings and key service components
- Revenue estimates
- Identification of the company's strategy, emphasis and new developments
- Analysis of the profile of the company's customer base, including the company's targeting strategy and examples of current contracts
- Analysis of the company's strengths, weaknesses and outlook.
Key Findings & Highlights:
Genpact is a global provider of business process management and technology services. Genpact provides support for LA&P BPO clients, in areas including: whole life; universal life; variable life; term; trauma/living/income protection; and superannuation products, as well as long-term care and annuities products. Genpact is planning to develop these offerings by investing further in policy administration and increasing the use of analytics - particularly claims analytics and predictive modeling.Genpact has seven delivery centers, four of which are located in India, one in the U.S., one in China and another in Romania.
In terms of its target geographies, Genpact will continue to target the U.S., but is looking to increase efforts in Latin America and China.